Effect of Atorvastatin on elderly patients with chronic kidney diseases complicated with hyperlipidemia
10.3760/cma.j.issn.0254-9026.2018.07.013
- VernacularTitle:阿托伐他汀治疗老年慢性肾病伴高脂血症患者的效果
- Author:
Gongling WEN
1
;
Changming WEN
;
Baozhao ZHANG
;
Jiachuan GONG
;
Jie ZHAO
Author Information
1. 473000,河南省南阳市中心医院神经内科
- Keywords:
Nephropathy;
Hyperlipidemia;
Blood lipids;
Proinflammatory factors
- From:
Chinese Journal of Geriatrics
2018;37(7):779-782
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of Atorvastatin on reducing the levels of inflammatory factors and on improving the quality of life in elderly patients with chronic kidney disease complicated with hyperlipidemia.Methods One hundred patients with chronic kidney disease accompanied with hyperlipidemia were enrolled from March 2016 to March 2017,and randomized into two groups:a control group undergoing conventional treatment with anticoagulant,diet control and standard glucocorticosteroid,and an observation group receiving Atorvastatin as add-on therapy to conventional treatment.Improvements of serum levels of inflammatory factors and blood lipid indices as well as total curative effect were compared between the two groups.Results The total effective rate was significantly higher in the observation group[94.0％ (47/50)]than in the control group (76.0％,38/50)(x2 =6.352,P＜0.05).After treatment,the improvements of blood lipid indices(TC,TG,LDL-C,HDL-C)were more in the observation group than in the control group(t =71.804,10.544,15.266,3.499,all P＜0.05).Before treatment,the serum levels of TNF-alpha,CRP and the 24h urine protein had no statistically significant differences between control and observation groups(P =0.406 or 0.678,respectively),but the levels in post-vs.pre-treatment were statistically significant lower in TNF-alpha[(1.1 ± 0.2) vs.(1.8 ± 0.3) μg/L],CRP [(8.2 ± 0.1) vs.(9.3 ± 0.1) mg/L] and 24h urine protein[(1.1±0.7)vs.(2.3±1.1)g/24 h](all P＜0.05).Conclusions Atorvastatin as add-on treatment to conventional therapy of chronic kidney diseases complicated with hyperlipidemia in the elderly has significant effects on controlling dyslipidemia and reducing inflammatory reactions so as to improve patients' quality of life.
